Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Maja Agung Latexindo Tbk's revenue for the
three
months ended in Mar. 2026 was Rp36,000 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was Rp152,177 Mil.
PT Maja Agung Latexindo Tbk's Revenue per Share for the
three
months ended in Mar. 2026 was Rp5.68.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was Rp24.02.
Warning Sign:
PT Maja Agung Latexindo Tbk revenue per share has been in decline for the last 5 years.
During the past 6 years, PT Maja Agung Latexindo Tbk's highest 3-Year average Revenue per Share Growth Rate was 17.20% per year. The lowest was -29.90% per year. And the median was -29.20% per year.
PT Maja Agung Latexindo Tbk (ISX:SURI) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
PT Maja Agung Latexindo Tbk Revenue Related Terms
PT Maja Agung Latexindo Tbk Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, PT Maja Agung Latexindo Tbk's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Maja Agung Latexindo Tbk Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Maja Agung Latexindo Tbk's Revenue distribution charts can be found below:
* The bar in red indicates where PT Maja Agung Latexindo Tbk's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp152,177 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Maja Agung Latexindo Tbk (ISX:SURI) has a Revenue of Rp152,177 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on PT Maja Agung Latexindo Tbk and its competitors.
Is PT Maja Agung Latexindo Tbk's Revenue too high?
PT Maja Agung Latexindo Tbk's current Revenue is Rp152,177 Mil. Overall, PT Maja Agung Latexindo Tbk has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does PT Maja Agung Latexindo Tbk's Revenue compare to ISRG and BDX?
PT Maja Agung Latexindo Tbk's Revenue of Rp152,177 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on PT Maja Agung Latexindo Tbk and its competitors. PT Maja Agung Latexindo Tbk's current Revenue is Rp152,177 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Maja Agung Latexindo Tbk stock overvalued right now?
PT Maja Agung Latexindo Tbk (ISX:SURI) has a current Revenue of Rp152,177 Mil. The current Revenue is Rp152,177 Mil. PT Maja Agung Latexindo Tbk's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For PT Maja Agung Latexindo Tbk (ISX:SURI), the current Revenue is Rp152,177 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Maja Agung Latexindo Tbk specializes in the production of latex gloves, made from natural rubber, and is a primary choice in the medical and industrial sectors. The company's business includes business of making rubber goods for health support needs, such as contraceptive gloves (birth control)/ condoms, pacifiers and compresses, medical rubber gloves, and urinary catheters (folley catheter). Its segments include Gloves and Concentrated latex.
28GF Score
Get the complete analysis for ISX:SURI
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SURI has been successfully added to your 
